The COVID-19 pandemic has transformed the face of psychiatry over a very short time
period. Given the detrimental impact of the pandemic on mental health and the economy …

Major depressive disorder (MDD) is an often chronic and/or recurrent disorder that is
associated with dysfunctions in multiple aspects of life including work and non-workrelated …

The health issue addressed is the unmet need to universally screen and treat depression,
which is one of the most common mental health disorders among adults in the United States …

Irritability in pediatric samples is associated with higher rates of subsequent suicide-related
outcomes. No study, to date, has evaluated the longitudinal association between irritability …

Background Unless implementation of systematic depression screening is associated with
timely treatment, quality measures based on screening are unlikely to improve outcomes …

Background This study included evaluation of the effectiveness of vortioxetine, a treatment
for adults with major depressive disorder (MDD), using patient-reported outcome measures …

Measurement-based care (MBC) involves the systematic use of standardized measurements
to inform treatment decisions. MBC can enhance clinical decision-making and quality of care …

Integration of measurement-based care (MBC) into clinical practice has shown promise in
improving treatment outcomes for depression. Yet, without a gold standard measure of MBC …

It is clear that depression leads to significant morbidity and mortality. Depression is a leading
cause of global health-related burdens. Although there are effective treatments (described in …

Major depressive disorder (MDD) is a chronic and recurrent illness that affects 20% of adults
during their lifetime and is one of the leading causes of suicide in the United States. A …